Dedicated Research Sites
MAC owns and operates a growing number of state-of-the-art Dedicated Research Sites. This includes our MHRA Accredited Phase 1 Unit (Read more) located in Citylabs 1.0 on the Manchester Royal Infirmary Campus in the heart of Manchester and our network of late phase sites. All Sites are staffed by MAC employees who follow a well proven and successful business management model, where an extensive library of Company SOPs, policies and training programs are implemented to ensure successful execution and delivery of every clinical trial.
MAC’s operating and quality systems ensure that the highest quality clinical data is provided to monitors on a multi-site studies basis, where greater numbers of patients are recruited, often more quickly across MAC’s Sites than can be achieved at other sites. MAC’s business focus is to recruit patients on budget and on time.
MAC’s Dedicated Research Sites offer comfortable patient accommodation where our experienced and professional staff understand patient needs and expectations. By positively engaging directly with patients MAC’s Patient Recruitment teams are able to retain more self-motivated, interested and happy patients on clinical trials than can be experienced at other sites. MAC’s patient retention rate on long-term studies of more than one year is 86% and across studies on <1 year, 94%.
MAC’s Sites are geographically located spanning high density population conurbations in the UK, offering ease of access to over 20 million patients across a wide range of disease and therapy areas. Every MAC Dedicated Research Site follows a centralised management structure guided by ICH GCP trained clinical staff conducting and overseeing clinical studies to the highest standards. MAC’s modern Sites are able to host study monitors and provide patients with a friendly, comfortable and reliable environment in which to participate in clinical research.